Aspen Aerogels (ASPN) Equity Average (2014 - 2026)

Aspen Aerogels (ASPN) has 13 years of Equity Average data on file, last reported at $224.5 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 51.69% year-over-year to $224.5 million; the trailing twelve-month figure through Mar 2026 stood at $224.5 million (down 51.69% YoY), and the FY2025 full-year result was $425.1 million, down 22.9% from the prior year.
• Equity Average for Q1 2026 stood at $224.5 million, down from $270.6 million in the prior quarter.
• Across five years, Equity Average topped out at $561.2 million in Q4 2024 and bottomed at $155.0 million in Q1 2022.
• The 5-year median for Equity Average is $414.9 million (2023), against an average of $364.3 million.
• The widest annual swing landed in 2023, when Equity Average jumped 183.85%; it then plunged 51.78% in 2025.
• A 5-year view of Equity Average shows it stood at $314.9 million in 2022, then surged by 42.55% to $448.9 million in 2023, then advanced by 25.0% to $561.2 million in 2024, then slumped by 51.78% to $270.6 million in 2025, then retreated by 17.04% to $224.5 million in 2026.
• The last three Equity Average figures came in at $224.5 million (Q1 2026), $270.6 million (Q4 2025), and $307.3 million (Q3 2025), per Business Quant data.

Peer Comparison